Saturday, July 11, 2026

Drug profile · INN

befotertinib

befotertinib is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — befotertinib
Class
Route
Patents
0
Programs
2
Data quality
0.70

Quick answer

befotertinib is an FDA-listed pharmaceutical active ingredient.

Key facts

INN befotertinib

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. Befotertinib combined Bevacizumab Phase 2 · Chinese Academy of · EGFR
  2. befotertinib Phase 2 · Chinese Academy of · NSCLC (Non-small Cell Lung Cancer)

Frequently asked questions

What is befotertinib?

befotertinib is an FDA-listed pharmaceutical active ingredient.